Abstract: The termination impedance of a memory agent may be selected dynamically. A transmission line may be simultaneously terminated with a first impedance at first memory agent and a different impedance at a second memory agent. A memory agent may have a terminator with at least two termination values and logic to dynamically select the termination values. Other embodiments are described and claimed.

Abstract: An optical switch having a housing, a light source and a light detector. The light source and light detector are located remote from the housing, The light source is connected to the housing with a first light guide, and the light detector is connected to the housing with a second light guide. The first and second light guide cables have distal ends positioned through the housing and are optically aligned but separated by a gap. The switch includes a device to interrupt a light beam that is usually adapted to removably occupy the gap.

Abstract: A reactor chamber for placement in a wastewater treatment system, where the reactor chamber has a chamber formed from a sidewall which forms an interior of the chamber. The sidewall has a top portion and a bottom portion and fixed channel growth media positioned in the interior of the chamber. The fixed channel growth media is positioned below the top of the sidewall, so that when positioned in a treatment system, most of the growth media is located below the water level in the treatment system. The top of the sidewall near the water level (when positioned in a treatment system) is substantially impermeable to wastewater. The reactor includes an air distribution manifold system having a series of air release sites positioned below the fixed channel growth media and adapted to release air which disperses upwardly through the fixed channel growth media. Influent is discharged into the treatment tank near the air discharge sites.

Abstract: Embodiments of the invention are generally directed to systems, methods, and apparatuses for polarity driven on-die termination. In some embodiments, an integrated circuit includes an input/output (I/O) circuit to receive a command and an on-die termination (ODT) pin to receive one or more ODT signals. The integrated circuit may further include control logic coupled to the ODT pin, the control logic to enable, at least in part, a multiplexing of an ODT activation signal and an ODT value selection signal on the ODT pin, the control logic further to control a length of termination based, at least in part, on the command. Other embodiments are described and claimed.

Abstract: Embodiments of the invention are generally directed to systems, methods, and apparatuses for time-multiplexed dynamic on-die termination. In an embodiment, an integrated circuit receives, during a first clock, an on-die termination (ODT) activation signal at its ODT pin. The integrated circuit also receives, during a second clock, an ODT value selection signal on its ODT pin. In an embodiment, the integrated circuit prevents a reset of the state of the ODT activation signal for a predetermined period of time to enable the multiplexing of signals on the ODT pin. Other embodiments are described and claimed.

Abstract: Embodiments of the invention are generally directed to systems, methods, and apparatuses for dynamic on-die termination launch latency reduction. In some embodiments, an integrated circuit includes an input/output (I/O) circuit to receive a command and a termination resistance circuit to provide a termination resistance for the I/O circuit. The integrated circuit may further include control logic to establish an initial termination resistance during a preamble associated with the command. Other embodiments are described and claimed.

Abstract: An apparatus to generate a playlist of media created by emerging artists for use by a media distribution center in response to purchasing decisions stored on a website comprises a storage unit configured to receive and store a plurality of media titles from a plurality of emerging artists, an interface for communicating data associated with at least a portion of the stored media titles, and a processor in communication with said storage unit and said interface. The processor is configured to permit a plurality of users to purchase a media title from the emerging artists, record sales data associated with the media titles, generate a playlist of selected media titles in response to parameters associated with the media titles and selected by a media distribution center, wherein at least one of the parameters is related to a the sales data, and transmit data associated with the selected media titles to the interface.

Abstract: An embodiment may comprise memory with a memory array, a resistor coupled to a reference voltage, on die termination circuitry coupled with the resistor, and an input coupled to the on die termination circuitry and coupled with the memory array, the input to receive a calibration command to stop use of the input and the memory array and calibrate the on die termination circuitry with the resistor coupled to the reference voltage. Other embodiments are disclosed herein.

Abstract: The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Abstract: The present invention relates to dihydropyrrole compounds of Formula (I) that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Abstract: The present invention is directed to the identification, characterization and three-dimensional structure of a novel ligand binding site of KSP. Binding of ligands to the novel binding site result in a conformational change in the three-dimensional structure of the protein and a modulation of the activity of KSP. This conformational change in turn results in the formation of a novel binding pocket in the KSP protein, which comprises the novel binding site of the instant invention.

Abstract: The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Abstract: The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Abstract: A carrier sheet comprising a printed paper sheet having an integrated detachable card with a magnetic backing and method of manufacturing same is described. The carrier sheet is comprised of a printed paper sheet having printed matter on at least a front face thereof. The printed matter contains card information printed in a card area. A polyfilm patch is adhered over the card area and over the card information printed thereon. A thin flexible patch of magnet material is adhesively secured on a rear face of the paper sheet and extends over the card area. A die-cut is made in the sheet and delineates the contour of the card area and extends through the polyfilm patch, the paper sheet and partly into the patch of magnet material to form a burstable region along said die-cut to hold the card in the carrier sheet. The die-cut can have any ornamental shape.

Abstract: An inlet seal assembly for sealing an injection port member in a chromatography instrument, comprising an injection port member having a bottom surface with a raised metal ring, an inlet seal member with an upper surface, a peripheral groove formed in the upper surface of the inlet seal member, a soft ring made of resinous plastic material positioned in the peripheral groove of the inlet seal member opposite the raised metal sealing ring of the injection port member, a reducing nut holding the inlet seal member against the injection port member, and threads connecting the reducing nut to the injection port member whereby to press the soft ring of the inlet seal member against the raised metal sealing ring of the injection port member to form a seal between the sealing ring and the injection port member. A method of making and using the inlet seal assembly.

Abstract: A valve system includes a valve assembly, and an actuator for operating the valve assembly. The actuator includes a housing and a shaft extending through the housing. The shaft is moveable within a range of motion during operation of the valve assembly. The valve system also includes a valve position monitor for monitoring the position of the valve assembly. The valve position monitor includes at least one trigger and a corresponding stationary stop. The trigger is moveable with respect to the stationary stop within a range of motion. The range of motion of the trigger corresponds to at least a portion of the range of motion of the shaft. At least a portion of the range of motion of the trigger extends into the housing of the actuator.

Abstract: The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Abstract: The present invention provides methods for profiling mRNA production in single cells, in particular, during disease stages. The invention also provides a method for monitoring gene expression in a single cell which has been isolated from tissue. The methods of the present invention may be used to diagnose or monitor the progression of disease.

Abstract: The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Abstract: The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.